|
|
| | 1-(4-Methoxyphenyl)piperazine dihydrochloride Basic information |
| | 1-(4-Methoxyphenyl)piperazine dihydrochloride Chemical Properties |
| Melting point | 240 °C (dec.)(lit.) | | storage temp. | -20°C Freezer | | solubility | DMF: 5 mg/ml; DMSO: 30 mg/ml; Methanol: 1 mg/ml; PBS (pH 7.2): 10 mg/ml | | form | powder to crystal | | color | White to Light yellow to Light red | | Water Solubility | very faint turbidity | | Sensitive | Hygroscopic | | BRN | 4275784 | | InChI | InChI=1S/C11H16N2O.2ClH/c1-14-11-4-2-10(3-5-11)13-8-6-12-7-9-13;;/h2-5,12H,6-9H2,1H3;2*1H | | InChIKey | MMXANKLJIHSIQH-UHFFFAOYSA-N | | SMILES | N1(C2=CC=C(OC)C=C2)CCNCC1.[H]Cl.[H]Cl | | CAS DataBase Reference | 38869-47-5(CAS DataBase Reference) |
| Hazard Codes | Xi | | Risk Statements | 36/37/38 | | Safety Statements | 28A-26-36-24/25 | | RIDADR | 2811 | | WGK Germany | 3 | | HazardClass | 6.1 | | PackingGroup | III | | HS Code | 29349990 | | Storage Class | 11 - Combustible Solids |
| | 1-(4-Methoxyphenyl)piperazine dihydrochloride Usage And Synthesis |
| Description |
1-(4-Methoxyphenyl)piperazine dihydrochloride is a piperazine derivative with euphoric, stimulant properties comparable to those produced by amphetamine. It is assumed to have a mixed mechanism of action, with serotonergic and dopamine antagonistic properties in a similar fashion to 3,4-methylenedioxymethamphetamine. Also, its metabolism has been described. This product is intended for research and forensic purposes.
| | Chemical Properties | Off-White Powder | | Uses | An intermediate in the synthesis of Itraconazole (I937500). | | Uses |
1-(4-Methoxyphenyl)piperazine dihydrochloride is a piperazine derivative with euphoric, stimulant properties comparable to those produced by amphetamine. It is assumed to have a mixed mechanism of action, with serotonergic and dopamine antagonistic properties in a similar fashion to 3,4-methylenedioxymethamphetamine. Also, its metabolism has been described. This product is intended for research and forensic purposes.
| | References | [1] ROLAND F STAACK Hans H M. Metabolism of designer drugs of abuse.[J]. Current drug metabolism, 2005, 6 3: 259-274. DOI: 10.2174/1389200054021825
[2] M.D. ARBO H. F C M L Bastos. Piperazine compounds as drugs of abuse[J]. Drug and alcohol dependence, 2012, 122 3: Pages 174-185. DOI: 10.1016/j.drugalcdep.2011.10.007 |
| | 1-(4-Methoxyphenyl)piperazine dihydrochloride Preparation Products And Raw materials |
|